CH565798A5 - - Google Patents

Info

Publication number
CH565798A5
CH565798A5 CH1777269A CH1777269A CH565798A5 CH 565798 A5 CH565798 A5 CH 565798A5 CH 1777269 A CH1777269 A CH 1777269A CH 1777269 A CH1777269 A CH 1777269A CH 565798 A5 CH565798 A5 CH 565798A5
Authority
CH
Switzerland
Application number
CH1777269A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE759512D priority Critical patent/BE759512A/fr
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to CH1777269A priority patent/CH565798A5/xx
Priority to NL7015355A priority patent/NL159385B/xx
Priority to CA098,431A priority patent/CA983938A/en
Priority to FR7042500A priority patent/FR2077539B1/fr
Priority to DE19702058248 priority patent/DE2058248C3/de
Priority to GB5640770A priority patent/GB1287839A/en
Priority to DK607170A priority patent/DK143109C/da
Priority to SE1613270A priority patent/SE391718B/xx
Priority to JP10450970A priority patent/JPS4932551B1/ja
Publication of CH565798A5 publication Critical patent/CH565798A5/xx
Priority to NLAANVRAGE7901867,A priority patent/NL169475C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH1777269A 1969-11-29 1969-11-29 CH565798A5 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
BE759512D BE759512A (fr) 1969-11-29 Lactone
CH1777269A CH565798A5 (fr) 1969-11-29 1969-11-29
NL7015355A NL159385B (nl) 1969-11-29 1970-10-20 Werkwijze voor de bereiding van een optisch actief lacton.
CA098,431A CA983938A (en) 1969-11-29 1970-11-18 (+)-cis-1,3-dibenzyl-hexahydro-1h-furo (3,4-d) imidazole-2,4-dione
DE19702058248 DE2058248C3 (de) 1969-11-29 1970-11-26 imidazol-2,4-dion und ein Verfahren zu dessen Herstellung
FR7042500A FR2077539B1 (fr) 1969-11-29 1970-11-26
GB5640770A GB1287839A (fr) 1969-11-29 1970-11-27
DK607170A DK143109C (da) 1969-11-29 1970-11-27 Optisk aktiv lacton til anvendelse som mellemprodukt i syntesen af (+)-biotin og fremgangsmaade til fremstilling af den optisk aktive lacton
SE1613270A SE391718B (sv) 1969-11-29 1970-11-27 Ny optiskt aktiv lakton till anvendning vid syntes av (+)-biotin jemte forfarande for framstellning av laktonen
JP10450970A JPS4932551B1 (fr) 1969-11-29 1970-11-28
NLAANVRAGE7901867,A NL169475C (nl) 1969-11-29 1979-03-08 Werkwijze voor de bereiding van een optisch actief lacton.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1777269A CH565798A5 (fr) 1969-11-29 1969-11-29

Publications (1)

Publication Number Publication Date
CH565798A5 true CH565798A5 (fr) 1975-08-29

Family

ID=4427992

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1777269A CH565798A5 (fr) 1969-11-29 1969-11-29

Country Status (10)

Country Link
JP (1) JPS4932551B1 (fr)
BE (1) BE759512A (fr)
CA (1) CA983938A (fr)
CH (1) CH565798A5 (fr)
DE (1) DE2058248C3 (fr)
DK (1) DK143109C (fr)
FR (1) FR2077539B1 (fr)
GB (1) GB1287839A (fr)
NL (1) NL159385B (fr)
SE (1) SE391718B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0081047B1 (fr) * 1981-12-07 1985-12-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Procédé pour la préparation d'une lactone active du point de vue optique et produits résultant de ce procédé
DE3150723A1 (de) * 1981-12-22 1983-06-30 Basf Ag, 6700 Ludwigshafen Verbessertes verfahren zur herstellung von 1,3-disubstituierten 4,5-cis-dicarboxy-2-imidazolidonen
CH670644A5 (fr) * 1986-12-18 1989-06-30 Lonza Ag
CH671227A5 (fr) * 1986-12-02 1989-08-15 Lonza Ag
US5162540A (en) * 1986-12-18 1992-11-10 Lonza Ltd. Process for the production of (+) biotin
FI95034C (fi) * 1989-03-15 1995-12-11 Lonza Ag Menetelmä 1,3-substituoidun tetrahydro-1H-tieno/3,4-d/-imidatsol-2(3H)-on-4-ylideenipentaanihappoesterin valmistamiseksi
FI935609A (fi) * 1992-12-18 1994-06-19 Lonza Ag Dihydrofuroimidatsolijohdannaisten asymmetrinen hydraus
CA2134441A1 (fr) * 1993-04-20 1994-10-27 Martin Eyer Hydrogenation asymmetrique de derives furoimidazole
CA2122511A1 (fr) * 1993-05-14 1994-11-15 John Mcgarrity Hydrogenation asymetrique de derives furoimidazoliques
DE10033284A1 (de) * 2000-07-07 2002-01-17 Merck Patent Gmbh Verfahren zur Herstellung von (+)-Biotin
TW200300676A (en) 2001-12-04 2003-06-16 Tanabe Seiyaku Co Biotin intermediate and its production
CN113121549B (zh) * 2019-12-31 2022-08-26 江西天新药业股份有限公司 立体选择性合成手性内酯的方法和手性化合物及其应用

Also Published As

Publication number Publication date
CA983938A (en) 1976-02-17
NL7015355A (fr) 1971-06-02
DE2058248C3 (de) 1980-12-18
JPS4932551B1 (fr) 1974-08-31
FR2077539A1 (fr) 1971-10-29
DK143109C (da) 1981-09-21
DK143109B (da) 1981-03-30
GB1287839A (fr) 1972-09-06
FR2077539B1 (fr) 1973-02-02
BE759512A (fr) 1971-05-27
NL159385B (nl) 1979-02-15
DE2058248B2 (de) 1980-04-10
DE2058248A1 (de) 1971-06-09
SE391718B (sv) 1977-02-28

Similar Documents

Publication Publication Date Title
AU465413B2 (fr)
FR2077539B1 (fr)
AU450150B2 (fr)
CS151036B2 (fr)
CS149920B2 (fr)
AU2355770A (fr)
AU5712069A (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU470661B1 (fr)
AT308690B (fr)
AU442380B2 (fr)
AU442538B2 (fr)
AU410358B2 (fr)
AU442535B2 (fr)
AU442463B2 (fr)
AU4923469A (fr)
AU4949169A (fr)
CS149297B1 (fr)
AU1036070A (fr)
AU5598769A (fr)
AR203167Q (fr)
CS148853B1 (fr)
AU5109569A (fr)
AU5077469A (fr)

Legal Events

Date Code Title Description
PL Patent ceased